Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Patel

Showing results (551-560 of 596) with videos related to

Pageof 60
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2021
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen TestingKimberly E Hanson, Osama Altayar, Angela M Caliendo, et al.
Science Translational Medicine|April 24, 2015
Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humansAnkit Bharat, Scott A Cunningham, G R Scott Budinger, et al.
Nature Microbiology|September 5, 2018
Global spread of three multidrug-resistant lineages of Staphylococcus epidermidisJean Y H Lee, Ian R Monk, Anders Gonçalves da Silva, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2024
ARGONAUT-IV: susceptibility of carbapenemase-producing <i>Klebsiella pneumoniae</i> to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibutenMichael R Jacobs, Caryn E Good, Ayman M Abdelhamed, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2024
ARGONAUT-III and -V: susceptibility of carbapenem-resistant <i>Klebsiella pneumoniae</i> and multidrug-resistant <i>Pseudomonas aeruginosa</i> to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepimeMichael R Jacobs, Ayman M Abdelhamed, Caryn E Good, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2023
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing (January 2023)Mary K Hayden, Kimberly E Hanson, Janet A Englund, et al.
Plos One|February 25, 2010
C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infectionKerryl E Piper, Marta Fernandez-Sampedro, Kathryn E Steckelberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2024
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic TestingMary K Hayden, Ibrahim K El Mikati, Kimberly E Hanson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IVScott R Evans, Thuy Tien T Tran, Andrea M Hujer, et al.
The Journal of Arthroplasty|October 27, 2018
General Assembly, Prevention, Operating Room - Personnel: Proceedings of International Consensus on Orthopedic InfectionsAndrea Baldini, Kier Blevins, Daniel Del Gaizo, et al.
Pageof 60

Showing results (551-560 of 596) with videos related to

Sort By:
Pageof 60
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2021
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen TestingKimberly E Hanson, Osama Altayar, Angela M Caliendo, et al.
Science Translational Medicine|April 24, 2015
Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humansAnkit Bharat, Scott A Cunningham, G R Scott Budinger, et al.
Nature Microbiology|September 5, 2018
Global spread of three multidrug-resistant lineages of Staphylococcus epidermidisJean Y H Lee, Ian R Monk, Anders Gonçalves da Silva, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2024
ARGONAUT-IV: susceptibility of carbapenemase-producing <i>Klebsiella pneumoniae</i> to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibutenMichael R Jacobs, Caryn E Good, Ayman M Abdelhamed, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2024
ARGONAUT-III and -V: susceptibility of carbapenem-resistant <i>Klebsiella pneumoniae</i> and multidrug-resistant <i>Pseudomonas aeruginosa</i> to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepimeMichael R Jacobs, Ayman M Abdelhamed, Caryn E Good, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2023
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing (January 2023)Mary K Hayden, Kimberly E Hanson, Janet A Englund, et al.
Plos One|February 25, 2010
C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infectionKerryl E Piper, Marta Fernandez-Sampedro, Kathryn E Steckelberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2024
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic TestingMary K Hayden, Ibrahim K El Mikati, Kimberly E Hanson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IVScott R Evans, Thuy Tien T Tran, Andrea M Hujer, et al.
The Journal of Arthroplasty|October 27, 2018
General Assembly, Prevention, Operating Room - Personnel: Proceedings of International Consensus on Orthopedic InfectionsAndrea Baldini, Kier Blevins, Daniel Del Gaizo, et al.
Pageof 60